Correlation Between Acumen Pharmaceuticals and Altice USA

Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Altice USA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Altice USA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Acumen Pharmaceuticals and Altice USA, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Altice USA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Altice USA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Altice USA.

Diversification Opportunities for Acumen Pharmaceuticals and Altice USA

0.24

Correlation Coefficient

Acumen Pharmaceuticals  Altice USA

Modest diversification

The 3 months correlation between Acumen and Altice is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Altice USA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Altice USA and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Altice USA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Altice USA has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Altice USA go up and down completely randomly.

Pair Corralation between Acumen Pharmaceuticals and Altice USA

Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to under-perform the Altice USA. In addition to that, Acumen Pharmaceuticals is 1.13 times more volatile than Altice USA. It trades about 0.0 of its total potential returns per unit of risk. Altice USA is currently generating about 0.01 per unit of volatility. If you would invest  395.00  in Altice USA on September 4, 2024 and sell it today you would lose (146.00) from holding Altice USA or give up 36.96% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Acumen Pharmaceuticals  vs.  Altice USA

Acumen Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Acumen Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Acumen Pharmaceuticals is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Altice USA

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Altice USA are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Altice USA unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Acumen Pharmaceuticals and Altice USA

The main advantage of trading using opposite Acumen Pharmaceuticals and Altice USA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Altice USA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altice USA will offset losses from the drop in Altice USA's long position.

The idea behind Acumen Pharmaceuticals and Altice USA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.